Back

PCSK9 inhibition for cholesterol lowering.

1 September 2019 (16:40 - 16:57)
Organised by:
Congress Presentation Part of: Success stories in translation from bench to bedside Drugs, Drug Targets ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Catherine Boileau

LVTS Inserm UMR1148, Paris (France)

3 More presentations in this session

Presentation thumbnail
Prolactin for peripartum cardiomyopathy.
Professor D. Hilfiker-Kleiner (Hannover, DE)
Presentation thumbnail
Tafamidis for cardiac amyloidosis.
Professor C. Rapezzi (Ferrara, IT)
Slides Video
Presentation thumbnail
sGLTII inhibitors for heart failure .
Doctor G. Lopaschuk (Edmonton, CA)
Slides Video

Access the full session

Session thumbnail
Success stories in translation from bench to bedside

The Event

Event poster

ESC Congress 2019

1 September 2019 16:40 CET
You may be interested in
thumbnail
Congress Presentation
PCSK9 inhibitors: effectiveness of treatment and changes in background lipid-lowering therapy in a real world Italian population. The AT-TARGET-IT study
26 August 2022
thumbnail
Webinar
New trial evidence in the field of lipid management
19 April 2024
thumbnail
Congress Presentation
Epigenetic regulation of PCSK9 expression by statins
26 August 2023
thumbnail
Congress Presentation
Evolocumab rapidly reverses impaired coronary endothelial function in six weeks in people living with HIV and in patients with dyslipidemia
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources